<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="article-commentary" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">61547</article-id><article-id pub-id-type="doi">10.7554/eLife.61547</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Toxicity</subject></subj-group></article-categories><title-group><article-title>Fishing for protective compounds</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-178622"><name><surname>Ciarimboli</surname><given-names>Giuliano</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4365-3656</contrib-id><email>gciari@uni-muenster.de</email><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="conf1"/><bio><p><bold>Giuliano Ciarimboli</bold> is in the Experimental Nephrology, Med. Clinic D, Muenster University Hospital, Muenster, Germany</p></bio></contrib><aff id="aff1"><institution>Experimental Nephrology, Med. Clinic D, Muenster University Hospital</institution><addr-line><named-content content-type="city">Muenster</named-content></addr-line><country>Germany</country></aff></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>03</day><month>09</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e61547</elocation-id><history><date date-type="received" iso-8601-date="2020-09-01"><day>01</day><month>09</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-09-01"><day>01</day><month>09</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Ciarimboli</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Ciarimboli</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-61547-v1.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="commentary-article" xlink:href="10.7554/eLife.56235"/><abstract><p>A new zebrafish study identifies compounds that shield ears and kidneys against an anticancer drug.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cisplatin</kwd><kwd>drug screen</kwd><kwd>toxicity</kwd><kwd>nephrotoxicity</kwd><kwd>dopamine</kwd><kwd>L-mimosine</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Zebrafish</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A new zebrafish study identifies compounds that shield ears and kidneys against an anticancer drug.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Template</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Wertman JN, Melong N, Stoyek MR, Piccolo O, Langley S, Orr B, Steele SL, Razaghi B, Berman JN. 2020. The identification of dual protective agents against cisplatin-induced oto-and nephrotoxicity using the zebrafish model. <italic>eLife</italic> <bold>9</bold>:e56235. doi: <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7554/eLife.56235">10.7554/eLife.56235</ext-link></p></boxed-text><p>Cancer treatments have become increasingly effective over the past few decades, but the chemotherapy drugs that kill tumour cells also damage healthy tissues. This can lead to serious side effects that go on to impair the quality of life of patients after recovery. For instance, cisplatin, a drug used to treat testicular cancer, is toxic to kidneys and hair cells in the ear that are necessary for hearing processes (<xref ref-type="bibr" rid="bib1">Daugaard, 1990</xref>; <xref ref-type="bibr" rid="bib2">Einhorn, 2002</xref>; <xref ref-type="bibr" rid="bib7">Rybak and Ramkumar, 2007</xref>; <xref ref-type="bibr" rid="bib5">Pabla and Dong, 2008</xref>; <xref ref-type="bibr" rid="bib4">Lanvers-Kaminsky et al., 2017</xref>). Now, in eLife, Jason Berman and colleagues in institutions across Canada – including Jamie Wertman as first author – report the results of a study screening for compounds that reduce the toxicity of cisplatin (<xref ref-type="bibr" rid="bib10">Wertman et al., 2020</xref>).</p><p>To do so, the team enlisted the zebrafish <italic>Danio rerio</italic>, a tiny freshwater tropical fish similar to humans at the molecular level, but can be bred cheaply and quickly (<xref ref-type="bibr" rid="bib8">Schartl, 2014</xref>). It has become an exceptionally important in vivo model for biomedical research, especially to test the toxicity of drugs such as cisplatin or the antibiotics gentamicin (<xref ref-type="bibr" rid="bib6">Rocha-Sanchez et al., 2018</xref>; <xref ref-type="bibr" rid="bib9">Swanhart et al., 2011</xref>). Indeed, even at the larval stage, the fish has easily accessible hair cells in its lateral line (a sensory organ under the skin), and a primitive, anatomically simple kidney (<xref ref-type="bibr" rid="bib9">Swanhart et al., 2011</xref>).</p><p>Wertman et al. examined whether 1200 compounds could protect the kidneys and lateral line hair cells of zebrafish larvae against the toxic effects of cisplatin. The screening highlighted 22 molecules, including two that offered the highest levels of protection: dopamine, a compound that nerve cells use to communicate, and L-mimosine, a rare plant non-protein amino acid similar to the amino acid tyrosine (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Their protective potential was confirmed in vivo in the primitive kidney and another population of hair cells in zebrafish larvae. In addition, dopamine and L-mimosine did not keep cisplatin from killing cancer cells grown in the laboratory.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Protective effects of dopamine and L-mimosine against the cancer drug cisplatin.</title><p>Treatment of zebrafish larvae with cisplatin (panel <bold>A</bold>) impairs the function (lightning bolt icon) of the fish's primitive kidney (pronephros), and of its anterior and posterior lateral line – the organs that display hair cells similar to the ones found in ears. Application of dopamine or L-mimosine (panel <bold>B</bold>) suppresses the toxic effects of cisplatin.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-61547-fig1-v1.tif"/></fig><p>The next step would be to investigate how dopamine and L-mimosine perform this protective role. Organic cation transporters are a family of proteins that help to carry molecules – including dopamine – into cells. In their absence, cisplatin is less toxic for ears and kidneys (<xref ref-type="bibr" rid="bib3">Hucke et al., 2019</xref>). It is therefore possible that dopamine and L-mimosine compete with cisplatin for access to the transporters: this would result in fewer cisplatin molecules accessing kidney and ear hair cells, ultimately protecting the organs against the cancer drug.</p><p>Finally, it is essential to demonstrate that dopamine and L-mimosine do not impair the anticancer activity of cisplatin in vivo, which could also be done in zebrafish larvae. In addition, this animal model could be useful to study neurotoxicity, another potential side effect of the drug. This would allow scientists to investigate whether the two compounds only protect specific organs, or globally interfere with cisplatin activity.</p><p>Confirming that dopamine and L-mimosine preserve the anticancer properties of cisplatin in vivo, together with fully understanding how they shield ears and kidneys from the drug’s toxicity should help to develop protective therapies. Ultimately, this would allow more aggressive cancer chemotherapy to be performed, and improve the quality of life of cancer survivors.</p></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daugaard</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Cisplatin nephrotoxicity: experimental and clinical studies</article-title><source>Danish Medical Bulletin</source><volume>37</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">2178884</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Einhorn</surname> <given-names>LH</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Curing metastatic testicular cancer</article-title><source>PNAS</source><volume>99</volume><fpage>4592</fpage><lpage>4595</lpage><pub-id pub-id-type="doi">10.1073/pnas.072067999</pub-id><pub-id pub-id-type="pmid">11904381</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hucke</surname> <given-names>A</given-names></name><name><surname>Rinschen</surname> <given-names>MM</given-names></name><name><surname>Bauer</surname> <given-names>OB</given-names></name><name><surname>Sperling</surname> <given-names>M</given-names></name><name><surname>Karst</surname> <given-names>U</given-names></name><name><surname>Köppen</surname> <given-names>C</given-names></name><name><surname>Sommer</surname> <given-names>K</given-names></name><name><surname>Schröter</surname> <given-names>R</given-names></name><name><surname>Ceresa</surname> <given-names>C</given-names></name><name><surname>Chiorazzi</surname> <given-names>A</given-names></name><name><surname>Canta</surname> <given-names>A</given-names></name><name><surname>Semperboni</surname> <given-names>S</given-names></name><name><surname>Marmiroli</surname> <given-names>P</given-names></name><name><surname>Cavaletti</surname> <given-names>G</given-names></name><name><surname>Schlatt</surname> <given-names>S</given-names></name><name><surname>Schlatter</surname> <given-names>E</given-names></name><name><surname>Pavenstädt</surname> <given-names>H</given-names></name><name><surname>Heitplatz</surname> <given-names>B</given-names></name><name><surname>Van Marck</surname> <given-names>V</given-names></name><name><surname>Sparreboom</surname> <given-names>A</given-names></name><name><surname>Barz</surname> <given-names>V</given-names></name><name><surname>Knief</surname> <given-names>A</given-names></name><name><surname>Deuster</surname> <given-names>D</given-names></name><name><surname>Zehnhoff-Dinnesen</surname> <given-names>AA</given-names></name><name><surname>Ciarimboli</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection</article-title><source>Archives of Toxicology</source><volume>93</volume><fpage>2835</fpage><lpage>2848</lpage><pub-id pub-id-type="doi">10.1007/s00204-019-02557-9</pub-id><pub-id pub-id-type="pmid">31493026</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanvers-Kaminsky</surname> <given-names>C</given-names></name><name><surname>Zehnhoff-Dinnesen</surname> <given-names>AA</given-names></name><name><surname>Parfitt</surname> <given-names>R</given-names></name><name><surname>Ciarimboli</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Drug-induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies</article-title><source>Clinical Pharmacology &amp; Therapeutics</source><volume>101</volume><fpage>491</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1002/cpt.603</pub-id><pub-id pub-id-type="pmid">28002638</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pabla</surname> <given-names>N</given-names></name><name><surname>Dong</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cisplatin nephrotoxicity: mechanisms and renoprotective strategies</article-title><source>Kidney International</source><volume>73</volume><fpage>994</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1038/sj.ki.5002786</pub-id><pub-id pub-id-type="pmid">18272962</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha-Sanchez</surname> <given-names>SM</given-names></name><name><surname>Fuson</surname> <given-names>O</given-names></name><name><surname>Tarang</surname> <given-names>S</given-names></name><name><surname>Goodman</surname> <given-names>L</given-names></name><name><surname>Pyakurel</surname> <given-names>U</given-names></name><name><surname>Liu</surname> <given-names>H</given-names></name><name><surname>He</surname> <given-names>DZ</given-names></name><name><surname>Zallocchi</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Quinoxaline protects zebrafish lateral line hair cells from cisplatin and aminoglycosides damage</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>15119</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-33520-w</pub-id><pub-id pub-id-type="pmid">30310154</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rybak</surname> <given-names>LP</given-names></name><name><surname>Ramkumar</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Ototoxicity</article-title><source>Kidney International</source><volume>72</volume><fpage>931</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1038/sj.ki.5002434</pub-id><pub-id pub-id-type="pmid">17653135</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schartl</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Beyond the zebrafish: diverse fish species for modeling human disease</article-title><source>Disease Models &amp; Mechanisms</source><volume>7</volume><fpage>181</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1242/dmm.012245</pub-id><pub-id pub-id-type="pmid">24271780</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanhart</surname> <given-names>LM</given-names></name><name><surname>Cosentino</surname> <given-names>CC</given-names></name><name><surname>Diep</surname> <given-names>CQ</given-names></name><name><surname>Davidson</surname> <given-names>AJ</given-names></name><name><surname>de Caestecker</surname> <given-names>M</given-names></name><name><surname>Hukriede</surname> <given-names>NA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Zebrafish kidney development: basic science to translational research</article-title><source>Birth Defects Research Part C: Embryo Today: Reviews</source><volume>93</volume><fpage>141</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1002/bdrc.20209</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wertman</surname> <given-names>JN</given-names></name><name><surname>Melong</surname> <given-names>N</given-names></name><name><surname>Stoyek</surname> <given-names>MR</given-names></name><name><surname>Piccolo</surname> <given-names>O</given-names></name><name><surname>Langley</surname> <given-names>S</given-names></name><name><surname>Orr</surname> <given-names>B</given-names></name><name><surname>Steele</surname> <given-names>SL</given-names></name><name><surname>Razaghi</surname> <given-names>B</given-names></name><name><surname>Berman</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The identification of dual protective agents against cisplatin-induced oto-and nephrotoxicity using the zebrafish model</article-title><source>eLife</source><volume>9</volume><elocation-id>e56235</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.56235</pub-id><pub-id pub-id-type="pmid">32720645</pub-id></element-citation></ref></ref-list></back></article>